Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze MDGL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MDGL investment potential.

What is MDGL stock price today?

Get real-time MDGL stock price, historical data, and price charts on Financhill. Track MDGL performance with our advanced analysis tools.

Is MDGL a good investment?

Evaluate MDGL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MDGL stock?

To buy MDGL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MDGL?

View detailed market capitalization data and company valuation metrics for MDGL on our comprehensive analysis page.

What is the P/E ratio of MDGL?

Use our fundamental analysis tools to view MDGL P/E ratio and compare valuation metrics with industry peers.

What are MDGL earnings?

View MDGL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Madrigal Pharmaceuticals, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

MDGL
Madrigal Pharmaceuticals, Inc.

Last Price:

$563.43

Seasonality Move:

13.5%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

Madrigal Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Madrigal Pharmaceuticals, Inc. has on average historically risen by 34.4% based on the past 18 years of stock performance.
Madrigal Pharmaceuticals, Inc. has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Is Madrigal Pharmaceuticals, Inc. Stock Undervalued?

The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $571.44. The Score for MDGL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Madrigal Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Madrigal Pharmaceuticals, Inc. has on average historically risen by 34.4% based on the past 18 years of stock performance.

Madrigal Pharmaceuticals, Inc. Stock Rating

Buy

Madrigal Pharmaceuticals, Inc. (MDGL) is a Buy

Is Madrigal Pharmaceuticals, Inc. overpriced?

Madrigal Pharmaceuticals, Inc. has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Madrigal Pharmaceuticals, Inc. Stock Price History

Is MDGL stock going to rise?

The current trend is moderately bullish and MDGL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

madrigalpharma.com

52-Week Data

52-Week High:

605.00

52-Week Low:

265.00

Prediction Charts

Market Cap:

13B

Price in USD:

571.44

Volume:

177.5K

Beta:

1.08

Technical Analysis

SMA50:

496.62

SMA100:

445.82

SMA200:

377.22

52-Wk Change:

88.92%

Stock Predictions

Is Madrigal Pharmaceuticals, Inc. stock public?

Yes, Madrigal Pharmaceuticals, Inc. is a publicly traded company.
What is the Madrigal Pharmaceuticals, Inc. stock quote today?

The Madrigal Pharmaceuticals, Inc. stock price is 571.44 USD today.
How to buy Madrigal Pharmaceuticals, Inc. stock online?

You can buy Madrigal Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-24	547.96	587.92	594.99	545.00
Nov-25	588.27	592.04	594.46	566.99
Nov-26	592.04	601.03	604.81	585.09
Nov-28	600.00	596.98	605.00	590.34
Dec-1	593.82	579.45	594.03	577.59
Dec-2	579.90	573.15	598.77	569.04
Dec-3	579.67	579.89	592.88	570.50
Dec-4	582.59	586.21	594.27	573.00
Dec-5	585.39	577.30	593.00	573.00
Dec-8	576.90	568.57	576.97	561.20
Dec-9	565.80	553.92	569.83	550.70
Dec-10	552.97	552.47	555.39	546.20
Dec-11	559.13	571.33	589.67	554.00
Dec-12	570.11	571.44	577.21	561.05

Madrigal Pharmaceuticals, Inc. Earnings

Madrigal Pharmaceuticals, Inc. Earnings Report: Per Share Madrigal Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Madrigal Pharmaceuticals, Inc. Forecast Revenue Growth

Madrigal Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.45 per share, and an increase next year of $15.15 per share.

* Madrigal Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.